SGI
PRAH

Summit Global Investments’s PRA Health Sciences, Inc. PRAH Stock Holding History

Summit Global Investments’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-76,652
Closed -$6.37M – 268
2020
Q1 		$6.37M Buy
76,652
+63,591
+487% +$6.2M 0.93% 42
2019
Q4 		$1.45M Buy
13,061
+3
+0% +$309 0.16% 104
2019
Q3 		$1.3M Sell
13,058
-48,102
-79% -$4.78M 0.15% 110
2019
Q2 		$6.06M Buy
+61,160
New +$5.84M 0.76% 45

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Summit Global Investments's PRAH Position: Q2 2020 in Review

Summit Global Investments sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2020, closing a stake of 76,652 shares — an estimated $6.37M sold.

Summit Global Investments first reported a position in PRAH in Q2 2019 and held it in 4 quarters. The position peaked at $6.37M in Q1 2020. 293 funds tracked by Wall St. Rank hold PRAH as of Q2 2020.

  • Summit Global Investments reported no remaining PRA Health Sciences, Inc. position as of Q2 2020 after selling out during the quarter.
  • Summit Global Investments sold 76,652 PRA Health Sciences, Inc. shares in Q2 2020, an estimated $6.37M.
  • Summit Global Investments first reported a position in PRA Health Sciences, Inc. in Q2 2019 and held it in 4 quarters.
  • Summit Global Investments's PRA Health Sciences, Inc. position peaked at $6.37M in Q1 2020.
  • 293 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2020.

Based on Summit Global Investments's 13F filing for Q2 2020, filed 11 Aug 2020.